rheumatology
Rheumatoid arthritis

Research institute halts large cardiovascular inflammation reduction trial

A US research institute has put an early stop to a large trial investigating whether taking low-dose methotrexate could prevent heart attacks, strokes, or death in people with prior MI and either type 2 diabetes or the metabolic syndrome. The halting of the large Cardiovascular Inflammation Reduction (CIRT) Trial. by the National Heart, Lung and Blood ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic